The graphs in the Aug 3 company update are quite good in giving a rough overview of Uscom1A sales figures for each year going back to 2012. Looks like around $30 million in total from that time. Its reasonable to assume these sales will increase into the future considering developments in the last couple of years and especially with the 2 new Uscom models becoming available which are likely intended for less acute situations, such as maternal hypertension.
Its also reasonable to assume the other new products will increasingly generate revenue, (hopefully according to the modelling in the updates).
Add to My Watchlist
What is My Watchlist?
